Aspirin worthwhile as primary CVD prevention in hypertension

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.480, 2005-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin worthwhile as primary CVD prevention in hypertension

By  

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Primary prevention of CVD with aspirin cost saving in Italy

By  

Inpharma, Vol. 1, Iss. 1500, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Aspirin not worth risks for primary CVD prevention

By  

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

GPs should recommend primary prevention with aspirin

By  

Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Aspirin Use for the Primary Prevention of Cardiovascular Disease in the Elderly

By Sarbacker G. Blair   Lusk Kathleen A.   Flieller Lauren A.   Van Liew Jeffrey R.  

The Consultant Pharmacist, Vol. 31, Iss. 1, 2016-01 ,pp. : 24-32

American Society of Consultant Pharmacists

Access to resources Recommend Favorite